期刊文献+

脑钠肽重组蛋白的表达及生物学活性的研究

Brain Natriuretic Peptide Recombine Proteins Expression and Activity Researchment
下载PDF
导出
摘要 目的比较脑钠肽(BNP)连接在不同载体中表达的BNP成熟肽蛋白和BNP前体蛋白的生物学活性差别。方法采用分子生物学技术构建重组质粒PGEX-20T—BNP32,PGEX-20T—BNP108,B11-BNP32和B11—BNP108分别对其进行PCR、双酶切和测序鉴定,然后将已测序鉴定的包含四种重组质拉的工程菌,转化至大肠埃希菌BL21菌中表达BNP成熟肽蛋白和BNP前体蛋白,并用ELISA法检测4种蛋白的生物学活性作用。结果在大肠埃希茵中表达的成熟肽蛋白BNP。2和前体蛋白BNP108经过纯化、复性后具有生物学活性。结论PGEx-20T—BNP52表达的成熟肽蛋白BNP32的生物学活性最强,为下一步单抗制备的优势蛋白。 Objective The difference between the biological activity of BNP mature polypeptides and its precursors was ex- amined in this paper. Methods Recombinant plasmid PGEX-20T-BNPa2,PGEX-20T-BNP108,B11-BNP32 and B11-BNP108 were constructed by molecuIar biological methods,which were identified by PCR ,restriction enzyme digestion and sequence analysis. Those four recombinant plasmids,identified by sequencing, were transformed into E. coli BL 21 and expressed BNP mature polypeptides and their corresponding precursors,whose biological activity was determined by EIA. Results BNP mature polypeptides BNP^2and its precursor BNP108 which were expressed in colon bacillus were reactive after purifi- cation and renaturation. Coaclusion BNP mature polypeptides which is expressed by PGEX-20T-BNP32 is most reactive and will be superior for inducing BNP-mAb in next step.
出处 《现代检验医学杂志》 CAS 2009年第4期27-30,共4页 Journal of Modern Laboratory Medicine
关键词 脑钠肽 成熟肽蛋白(BNP32) 前体蛋白(ENP108) brain natriuretic peptide(BNP) mature polypeptides protein(BNP32) precursors protein(BNP108)
  • 相关文献

参考文献12

  • 1Sudoh T,Kangwa K,Minamino N,et al.A natriuretic peptide in porcine brain[J].Nature,1988,322(5):78-81.
  • 2Latini R,Masson S,Wong M,et al.Incremental prognostic value of changes in B-type natriuretic peptide in heart failure[J].Am J Med,2006,119(70):23-30.
  • 3Maisel A.The coming of age of natriuretic peptides:the emperor does have clothes[J].J Am Coll Cardiol,2006,47(1):61-64.
  • 4Costello-Boerrigter LC,Boerrigter G,Redfield MM,et al.Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community:determinants and detection of left ventricular dysfunction[J].J Am Coll Cardiol,2006,47(2):345-353.
  • 5Hammerer-Lercher A,Ludwig W,Falkensammer G,et al.Natriuretic peptides as markers of mild forms of left ventricular dysfunction effects of assays on diagnostic performance of markers[J].Clin Chem,2004,50:1174-1183.
  • 6Sykes E,Karcher RE,Eisenstadt J,et al.Analytical relationships among Biosite,Bayer,and Roche methods for BNP and NT-proBNP[J].Am J Clin Pathol,2005,123:584-590.
  • 7Zaphiriou A,Robb S,Murray-Thomas T,et al.The diagnostic accuracy of plasma BNP and NT-proBNP in patients referred from primary care with suspected heart failure:results of the UK natriuretic peptide study[J].Eur J Heart Fail,2005,7:537-541.
  • 8Goetze JP,Jensen G,Moller S,et al.BNP and N-terminal proBNP are both extracted in the normal kidney[J].Eur J Clin Investig,2006,36:8-15.
  • 9Jourdain P,Jondeau G,Funck F,et al.Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure:the STARS-BNP multicenter study[J].J Am Coll Cardiol,2007,49:1733-1739.
  • 10Schou M,Gustafsson F,Nielsen PH,et al.Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state[J].Eur J Heart Fail,2007,9:68-74.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部